ABSTRACT
BACKGROUND: Each year more and more French travelers are visiting areas where malaria is endemic. The aim of this study was to assess prophylactic regimens used by French travelers and to determine whether they meet current published recommendations. METHODS: This 12 month transversal study (May 1, 1995 to April 31, 1996) was conducted in embarkment lounges of Roissy Charles de Gaulle Airport to eight "tropical" destinations. RESULTS: 3,446 French travelers were enrolled. Twenty two and three-fifths percent of travelers had not sought any advice. The percentages of travelers staying less than 3 months (n = 2899) at risk of malaria (i.e., using none or inadequate chemoprophylaxis) were, according to the destination: Brazil (20%), Gabon (83%), Ivory Coast (26%), Kenya (43%), Madagascar (39%), Thailand (22%), Venezuela (41%) and Vietnam (8%). The suitability of the prophylaxis according to the information source for travelers staying less than 3 months varied as follows: specialist physician (OR = 1), travel agent (OR = 1.01, CI = 0.9 - 1. 1), occupational physician (OR = 1.13, CI = 0.6 - 2.1), GP (OR = 1. 58, CI = 1.1 - 2.3), none (OR = 1.95, CI = 1.3 - 2.9), friends (OR = 3, CI = 1.8 - 5) and pharmacist (OR = 3.94, CI = 2.1 - 7.5). Suitability of prophylaxis also varied according to the type of trip: organized tour (OR = 1), business trip (OR = 1.04, CI = 0.8 - 1.4), adventure tourism (OR = 2.1, CI = 1.6 - 2.9) and visit to family or friends (OR = 2.3, CI = 1.7 - 3.1). CONCLUSIONS: This study shows that the quality of advice on antimalarial chemoprophylaxis varies markedly according to the source, and that nearly one in three French travelers (29.3 %, 850/2899) to tropical areas is at risk of malaria.
Subject(s)
Antimalarials/therapeutic use , Malaria, Falciparum/prevention & control , Travel , Adult , Female , France , Humans , Male , Middle Aged , Surveys and Questionnaires , Tropical ClimateABSTRACT
OBJECTIVE: To report on the unexpected improvement in major biological surrogate markers (CD4 T-cell count, HIV RNA viral load, and apoptosis level) during the periods of 'brown sugar' heroin intoxication (BSI) in 12 HIV-1-infected intravenous drug users, independently of their antiretroviral therapy, compared to the period of 'brown sugar' heroin withdrawal (BSW). METHODS: The patients were followed prospectively for a total of 417 months over 4 years. Twenty-four episodes of BSI and 24 periods of BSW were analyzed. RESULTS: (1) BSI: the mean (+/-SE) duration was 9+/-1.8 months; at onset, the mean +/-SE CD4 T-cell count was 401+/-88/mm3; at the end, an absolute increase of 346 CD4 T-cells/mm3 and a CD4 T-cell count relative variation of +131% was observed. Half of the patients showed an increase of CD4 T-cell count of more than 90% during their follow-up. The mean+/-SE of CD8 T-cell count increased significantly by 108%. (2) BSW: the mean +/- SE duration was 8.4+/-1.3 months; at onset, the mean +/-SE CD4 T-cell count was 695+/-78/mm3; at the end, an absolute decrease of 342 CD4 T-cells/mm3 and a CD4 T-cell count relative variation of -52% was observed. Half of the patients showed a decrease of CD4 T-cell count of more than 51%. (3) Circulating viral load appeared to be significantly higher during BSW (median: 452 000 Eq RNA/mL) than during BSI (median: 52 000 Eq RNA/mL); p<0.01. (4) Similarly, the apoptotic process affecting circulating lymphocytes was significantly lower during BSI than during BSW episodes. (5) The 4-year mortality rate was 7%, compared with 36% in HIV-positive former drug users (p<0.001). CONCLUSIONS: Taken together, these features suggest that 'brown sugar' heroin could have either immunomodulatory or antiretroviral properties. Confirmation of these findings and investigation of the role of the many substances in 'brown sugar' heroin are indicated.
Subject(s)
Travel , Tropical Climate , Vaccination , Adult , Bacterial Vaccines/administration & dosage , Diphtheria Toxoid/administration & dosage , Europe , Female , France , Hepatitis A/prevention & control , Hepatitis B Vaccines/administration & dosage , Humans , Male , Meningitis/prevention & control , Paris , Poliovirus Vaccine, Inactivated/administration & dosage , Tetanus Toxoid/administration & dosage , Typhoid-Paratyphoid Vaccines/administration & dosage , Viral Hepatitis Vaccines/administration & dosage , Viral Vaccines/administration & dosage , Yellow Fever/prevention & controlABSTRACT
BACKGROUND: Travel-related illnesses have been studied in visitors to developing countries, but no studies have examined the incidence of health problems in visitors to developed countries. METHODS: 4, 093 foreign tourists visiting Paris in August and attending to emergency medical care for acute health problems were included in an epidemiological survey conducted over 5 consecutive years. The objective was to determine what types of acute health problems occur in a foreign tourist population and to estimate the incidence of the main health hazards. RESULTS: Gastroenteritis represented the main cause of medical care in that population (from 14.5-21.9%) followed by traumatology, ENT problem, viral syndrome and dermatology which represented altogether 60-64% of all medical problems. Two factors were related to the distribution of diseases observed: age and nationality. The monthly incidence of gastroenteritis was estimated to be between 1.33 to 2.92 per 10,000 visitors, and the overall incidence of health problems between 8 to 10 per 10,000. CONCLUSIONS: Even if the incidence rate of gastroenteritis is low compared with developing countries, further studies are needed to support the hypothesis that gastroenteritis could be attributed to sanitary conditions in some restaurants of the French capital.
Subject(s)
Acute Disease/epidemiology , Travel/statistics & numerical data , Adolescent , Adult , Age Factors , Aged , Child , Child, Preschool , Developed Countries , Female , Gastroenteritis/epidemiology , Humans , Incidence , Infant , Male , Middle Aged , Paris/epidemiology , Retrospective Studies , SeasonsABSTRACT
For five consecutive years, five major Parisian institutions in charge of emergencies have participated in a prospective collection of medical data for foreign patients visiting Paris in August; 4093 subjects have been studied. Gastroenteritis represented the main cause in calling on emergency medical care (14.5 to 21.9%), followed by traumatology, ear-nose-throat problems, syndromes labelled as viral, skin problems: these five categories represented 60 to 64% of all the serious problems encountered by tourists. The statistical frequency of different causes in calling on emergency care varied significantly according to two variables: the tourists' age and nationality. The incidence of gastroenteritis is estimated at between 13 and 30 per 100,000 visitors and the incidence of pathological problems taken all together--at 80 to 100 per 100,000.
Subject(s)
Emergency Medical Services/statistics & numerical data , Epidemiology , Travel/statistics & numerical data , Adolescent , Adult , Age Factors , Aged , Child , Ethnicity/statistics & numerical data , Female , Gastroenteritis/epidemiology , Humans , Incidence , Male , Middle Aged , Otorhinolaryngologic Diseases/epidemiology , Paris/epidemiology , Population Surveillance , Prospective Studies , Skin Diseases/epidemiology , Virus Diseases/epidemiology , Wounds and Injuries/epidemiologyABSTRACT
A case of cotrimoxazole-induced meningoencephalitis in an HIV-infected patient without signs of AIDS is reported. The patient developed an apparently generalized seizure, of cotrimoxazole, 1 month after first taking a dose of this drug and a febrile coma after a second dose 3 weeks later. Lumbar puncture revealed eosinophilic aseptic meningitis. The patient quickly recovered without sequelae and was given antiretroviral therapy plus pentamidine aerosolized and pyrimethamine as prophylaxis for opportunistic infections. No other adverse effects were observed. The report describes the diagnosis of this case supported by a commentary, including a literature review.
Subject(s)
AIDS-Related Opportunistic Infections/prevention & control , Anti-Infective Agents/adverse effects , Eosinophilia/chemically induced , Meningitis, Aseptic/chemically induced , Trimethoprim, Sulfamethoxazole Drug Combination/adverse effects , Adult , Humans , MaleABSTRACT
To evaluate the stability of essential drugs stored in realistic tropical conditions, we have carried out a two-year prospective study in western Burkina Faso. Twenty-seven essential drugs were stored in a rural site and a urban one where temperature and hygrometry were recorded daily. Samples of each drug were taken for further analysis to the World Health Organization Collaborative Center for the Study of Stability of Drugs in Nantes, France every three months. Quantitative analysis showed that the majority of samples suffered no significant loss of their active ingredient. In contrast, ampicillin, erythromycin, sulfaguanidine, injectable furosemide, penicillin G, trimethoprim, and chloroquine showed more than a 10% quantitative loss of their active ingredient. Thus, it is not recommended that these essential drugs be stored for more than one year in a tropical climate.
Subject(s)
Drug Stability , Drug Storage , Drugs, Essential , Tropical Climate , Burkina Faso , Humidity , Prospective Studies , Temperature , Time FactorsABSTRACT
Diphtheria is a disease with a long history that almost completely disappeared from developed countries. In addition, until 1987, systemic infections involving Corynebacterium diphtheriae were rare. However, in 1990, an epidemic occurred in Russia. These two circumstances have provided the stimulus to gain insight into the situation in France. In fact, between 1987 and 1993, a total of 59 C. diphtheriae strains were isolated. Epidemiological data were collected for patients from whom 40 strains were isolated from normally sterile sites, including 34 from blood cultures, and half of the bacteremic patients developed endocarditis. Osteoarticular involvement was noted in 11 of these 40 patients, including 5 bacteremic patients. The fatality rate following bacteremia was 36%, despite specific antibiotic treatment (beta-lactams and aminoglycosides). The mean age of the participants was 38 years, with half of the patients subsisting under low socioeconomic conditions and suffering from homelessness or alcoholism. Apparently, the skin turned out to be the major route of transmission in this reemerging disease. Eighty-eight percent of the isolates belonged to the C. diphtheriae biotype mitis. These were found predominantly in the Paris area, and most were of the same ribotype. Those isolates originating from the overseas territories (Guyana and New Caledonia) belonged to C. diphtheriae biotype gravis. No strains were positive for the tox gene by PCR. This study attests to the persistent circulation in France of C. diphtheriae in the form of systemic infections. The matter is especially significant since these strains are nontoxigenic and are of a unique ribotype. The strains are, however, sensitive to most antibiotics, although 20% are rifampin resistant.
Subject(s)
Corynebacterium diphtheriae/classification , Diphtheria/microbiology , Adolescent , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/pharmacology , Bacterial Typing Techniques , Child , Child, Preschool , Corynebacterium diphtheriae/drug effects , Corynebacterium diphtheriae/genetics , Corynebacterium diphtheriae/isolation & purification , Diphtheria/drug therapy , Diphtheria/epidemiology , Diphtheria Toxin/analysis , Female , France/epidemiology , Humans , Male , Microbial Sensitivity Tests , Middle Aged , RNA, Bacterial/genetics , rRNA OperonABSTRACT
OBJECTIVE: To study the relationship between human immunodeficiency virus (HIV) infection and tuberculosis (TB) in a West African country. DESIGN: A cohort study in TB patients at the TB centre of Bobo Dioulasso, Burkina Faso. RESULTS: HIV seroprevalence rose from 12.5% in 1987 to 24.7% in 1990. Analysis of clinical findings showed that extra-pulmonary TB was not more frequent in HIV-positive patients (18.5%) than in HIV negative patients (17.3%). Four symptoms were independently associated with HIV infection: diarrhoea, lymphadenopathy, weight loss and oral candidiasis. At the end of six months of chemotherapy for TB (2SHRZ/4HR), the mortality rate among HIV-positive TB patients was 27%, versus 10% among HIV-negative TB patients (P < 0.001). There was no difference between treatment failure rates among HIV-positive patients (3.8%) and HIV-negative patients (3.9%). At the final evaluation, 18 months after the start of chemotherapy, the relapse rate was 8% in HIV-positive patients versus 5.6% in HIV-negative patients (NS). Global mortality rate during the whole study period was significantly higher in HIV-1 (40.3%) and HIV-1 + 2 (20%) patients than in HIV-2 (11.1%) and HIV-negative (12.9%) patients. CONCLUSION: We conclude that, according to previous African studies, despite a higher mortality rate due generally to HIV disease itself, short-course chemotherapy of 6 months is as effective in HIV-positive patients as in HIV-negative patients, and must be continued.
Subject(s)
AIDS-Related Opportunistic Infections/epidemiology , HIV Seroprevalence , HIV-1 , HIV-2 , Tuberculosis/epidemiology , AIDS-Related Opportunistic Infections/diagnosis , Adult , Africa/epidemiology , Age Distribution , Aged , Analysis of Variance , Cohort Studies , Developing Countries , Female , Humans , Incidence , Logistic Models , Male , Middle Aged , Risk Factors , Sex Distribution , Survival Rate , Tuberculosis/diagnosisSubject(s)
AIDS-Related Opportunistic Infections/epidemiology , Bacteroides Infections/epidemiology , Bacteroides fragilis , AIDS-Related Opportunistic Infections/drug therapy , Adult , Anti-HIV Agents/pharmacology , Anti-HIV Agents/therapeutic use , Antibiotic Prophylaxis , Bacteremia/microbiology , Bacteroides Infections/prevention & control , Bacteroides fragilis/drug effects , Female , France/epidemiology , Humans , Male , Middle Aged , Prospective StudiesABSTRACT
The purpose of this epidemiologic retrospective is to recognize the endemic nature of Lyme borreliosis in 'Berry', region of France. Fifty-nine cases have been reported here during the past six years (1988-1994). An erythema migrans (EM), or a late manifestation concurrent with positive ELISA-test represents the main inclusion criterion (case definition used by the CDC). The results reveal a high incidence considering the limited information available in France. The farmer has been found to be mainly at risk, with EM being observed in 49% of cases. In general, late manifestations are rarely described. Peripheral neurological manifestations occur more frequently than those reported in the USA. The steps taken as a result of our study of Lyme disease are in accordance with the recommendations of the World Health Organization.
Subject(s)
Agricultural Workers' Diseases/etiology , Lyme Disease/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Borrelia burgdorferi Group/isolation & purification , Child , Enzyme-Linked Immunosorbent Assay , Female , France/epidemiology , Humans , Incidence , Lyme Disease/complications , Lyme Disease/microbiology , Male , Middle Aged , Retrospective Studies , Rural Population , Seasons , Seroepidemiologic StudiesABSTRACT
In human immunodeficiency virus type 1 (HIV)-1-infected Black people, the circulating p24 antigen is hidden frequently in immune complexes, because of high titers of serum anti-p24 antibodies. In order to evaluate the prognostic values for progression of free and dissociated serum p24 antigen in Black people, sera from 45 HIV-1-infected Black patients, all at non-AIDS stages, were evaluated prospectively for p24 antigen by several assays; circulating free p24 antigen was measured by immunocapture ELISA only (method 1) and with ELAST amplification (method 2), and dissociated p24 antigen determined after glycine-HCl pretreatment of serum, by immunocapture ELISA only (method 3) and with ELAST amplification (method 4). Serum CD4 and CD8 cell counts, beta 2-microglobulin, and total IgA were determined also at least twice a year. Clinical events for AIDS were those included in the 1986 CDC classification for HIV infection. At entry, p24 antigen was found in 3 (6.7%) patients by method 1, in 7 (15.6%) by method 2, in 14 (31.1%) by method 3, and in 22 (48.9%) by method 4. Methods 3 and 4 were more sensitive than method 1 (P < 0.001) and method 2 (P < 0.001). The mean follow-up was 30 months. The free symptom survival times (mean +/- SD months) were significantly lower in patients being p24 antigen positive by method 1 [(+) 33 +/- 27 vs. (-) 61 +/- 15, P = 0.03), but they were similar in patients positive and in those negative for p24 antigen determined by method 2 [(+) 71 +/- 17 vs. (-) 74 +/- 9, P = 0.54], method 3 [(+) 76 +/- 12 vs. (-) 69 +/- 13.2, P = 0.80], and method 4 [(+) 79 +/- 9 vs. (-) 63 +/- 7, P = 0.71]. At 24 months, p24 antigen positivity did not correlate either with CD4 or CD4/CD8 slops, nor with beta 2-microglobulin or IgA variations. By contrast, a CD4 cell count below 200/mm3 at entry was significantly associated with disease progression. In conclusion, dissociated p24 antigenemia does not appear as a useful surrogate marker for progression in HIV-1-infected Black people.
Subject(s)
Black People , HIV Antigens/blood , HIV Core Protein p24/blood , HIV Infections/virology , HIV-1/immunology , Adult , Cross-Sectional Studies , Disease Progression , Follow-Up Studies , HIV Antigens/immunology , HIV Core Protein p24/immunology , HIV Infections/blood , HIV Infections/immunology , HIV-1/isolation & purification , Humans , Longitudinal Studies , Predictive Value of Tests , Prospective StudiesABSTRACT
A bicentre, controlled, randomized, open trial was carried out in order to compare the immunogenicity and the reactogenicity of PASTEUR MERIEUX Sérums et Vaccins inactivated Hepatitis A Vaccine on adults, when used with different routes of administration [intramuscular (i.m.), subcutaneous (s.c.) and needless injection using a Jet injector device]. Vaccines were given at two doses 6 months apart to 147 seronegative subjects. Anti-Hepatitis A virus (HAV) titres were performed at each visit by modified radioimmunoassay assay. After the first dose, 138 subjects except one seroconverted (s.c.). After booster dose, all subjects exhibited high levels of HAV antibodies. The higher titres were observed with Jet injector (GMT: 305 mIU ml-1 after the first dose and 3727 mIU ml-1 after the booster dose), followed by the i.m. route (210 mIU ml-1, 3152 mIU ml-1) and the s.c. route (165 mIU ml-1, 2082 mIU ml-1). No statistically significant differences were observed in the three paired comparisons (i.m. vs jet injector; jet vs s.c., im vs s. c.). This inactivated hepatitis A vaccine appeared to be highly immunogenic after one single dose and one booster 6 months later.
Subject(s)
Vaccines, Inactivated/adverse effects , Vaccines, Inactivated/immunology , Viral Hepatitis Vaccines/adverse effects , Viral Hepatitis Vaccines/immunology , Adult , Drug Administration Routes , Hepatitis A Vaccines , Humans , Injections, Intramuscular , Injections, Subcutaneous , Vaccines, Inactivated/administration & dosageABSTRACT
We report the case of a 32-year-old Malian man with abdominal tuberculosis revealing acquired immunodeficiency syndrome. A gastroscopy was made for epigastric pain and showed caseum in a digestive fistula with acid fast bacilli. Mycobacterium tuberculosis infection was confirmed by sputum culture. An early antituberculous therapy was prescribed. Outcome was good with rapid fistula closing and slower mass diminution of the abdominal lymph nodes. This case report confirms nodal tuberculosis as a possible cause of digestive fistulae. Rapid endoscopic diagnosis of this tuberculous fistula led to diagnosis of acquired immunodeficiency syndrome and early adapted medical treatment without invasive diagnostic methods.
Subject(s)
Acquired Immunodeficiency Syndrome/complications , Biliary Fistula/diagnostic imaging , Endoscopy, Gastrointestinal/methods , Gastric Fistula/diagnostic imaging , Tuberculosis, Lymph Node/complications , AIDS-Related Opportunistic Infections/complications , AIDS-Related Opportunistic Infections/drug therapy , Acquired Immunodeficiency Syndrome/diagnosis , Adult , Antitubercular Agents/therapeutic use , Biliary Fistula/etiology , Gastric Fistula/etiology , Humans , Male , Tomography, X-Ray Computed , Tuberculosis, Lymph Node/drug therapyABSTRACT
A recent survey shows that patients turn to modern medicine more than traditional medicine for most of their needs except rheumatic and neurological complaints. However, the preferences stated are influenced on the one hand by the much lower cost of traditional services, and on the other by official disapproval of animistic practices.